Yposkesi, an SK pharmteco company

🔬 Plan #France2030, l'@AgenceRecherche labellise "Biocluster" #Genother, un projet d'excellence en thérapie génique. 🧬Genother, un projet fondé par @GenethonFr @Genopole @APHP @Inserm @iGEM_Evry @spark_tx @yposkesi mesinfos.fr/ile-de-france/… #scientifique #essonne #label

Our @Marc90274 is attending the #ASGCT23 annual meeting and has met many old & new friends, including some at our sister company, @yposkesi! Stop by, say hello & learn how we can assist with your elemental impurities. yposkesi.com ampacanalytical.com/laboratory-ser… #CGT

Le laboratoire LAMBE @INC_CNRS au sein du campus évryen et génopolitain se réjouit de la labellisation #France2030 et du succès du biocluster Genother et félicite ses fondateurs @GenethonFr, @UnivEvry, @APHP, @Inserm, @SparkTherapeutics, @yposkesi, @Genopole @UnivParisSaclay

La France a été l’un des berceaux de la thérapie génique. Inauguration avec @BrunoLeMaire de la nouvelle usine d’@yposkesi, spécialisée dans ces thérapies. Un enjeu d’attractivité pour la France, de souveraineté sanitaire et d’accès aux médicaments innovants pour les patients.

Ce matin aux côtés de @beaudetstephane et Gilles Trystram, Président et Directeur du @Genopole, pour la visite du nouveau site de bioproduction d’@yposkesi des Ministres @BrunoLeMaire et @RolandLescure 🇫🇷 Très fière d’avoir cette pépite biotechnologique en Essonne !

🎙 Listen to our last podcast in collaboration with @PallCorporation, published by @Bio_Insights. In this new piece, experts are discussing the Improvement of #ViralVector #purification using Mustang Q membrane #chromatography. Link to the podcast: insights.bio/cell-and-gene-…

Meet the @Yposkesi team at the World Oncology Cell Therapy Congress today! #ViralVector #CDMO #WOCTCongress

Today is #DNAday! 🧬 We are celebrating the 70th anniversary of the discovery of the DNA double helix and the 20th anniversary of the Human Genome Project’s completion! #CDMO #ViralVector #Manufacturing

If you are in Barcelona this week for #CGMed23 and are interested in #ViralVector #Manufacturing, book a meeting with the Yposkesi team: yposkesi.com/meet-our-team-… The team will happily discuss our manufacturing capabilities and our new #Lentiviral vector platform, LentiSure™.

[ALA Client News] @Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields ala.associates/product-launch… #cellandgenetherapy #immunooncology #CDMO

🎉NEW! LentiSure™: Plug & Play Robust and Scalable, Lentivirus Manufacturing Platform! Launching today, our new platform gives you access to a #TimeEfficient and #CostEffective streamlined environment. More: lnkd.in/e73dy8Aw

The Yposkesi team is attending #CGMed23 next week in Barcelona! Interested in learning more about our #ViralVector #Manufacturing capabilities? Book a meeting with the team!

Meet us in Tours! During the next @Polepharma Bioproduction conference, meet our team to discuss #ViralVectorManufacturing. 📣 April 5 at 16h35, Cédrick will participate in “The challenges of innovation in bioproduction. How to accelerate the processes of tomorrow?” roundtable!

📣 We are hiring! Process Validation Lead, #CMC Project Manager, #Quality Assurance Lead and other! Several #positions are currently open at Yposkesi, browse our careers page to learn more and apply today! 👨‍🔬🧬 Mode details: yposkesi.com/careers/

#BioProcess Development is a crucial part of any #biopharmaceutical, whether it is an #ATPM or not. In our recent article, learn more about BioProcess Development and how it can help your clinical trials and commercialization. Link to the article: yposkesi.com/bioprocess-dev…

La semaine prochaine, ne manquez pas notre #webinar en partenariat avec @Polepharma et @aktehom : "L'approche Analytical Quality by Design". 📅 16 mars 2023 ⏰ 9h30 CET 🧾 Inscription: us06web.zoom.us/webinar/regist… #AQbD #CDMO #Analytics

Today is #RareDiseaseDay! Did you know that 300 million people worldwide live with a rare disease and 72% of rare diseases are genetic? Today brings awareness to those persons living with a rare disease and the clinical development of curative therapies. #shareyourcolours

Meet our team at #CARTCREurope!

☀ Will you be in sunny San Diego next week? Yposkesi will be there attending the Next Gen CAR & T Cell Therapies, part of #BPIWest. Interested in #ViralVector manufacturing? make sure to stop by booth #322 to discuss your project(s) 🧬👨‍🔬. More info: yposkesi.com/meet-our-team-…

Yposkesi will be attending @CAR_TCell next week in #London. If you are interested in #ViralVector manufacturing, stop by booth #29 to meet with Christophe and Marie. They will be happy to discuss your project 🧬👨‍🔬. yposkesi.com/meet-our-team-… #CDMO #Manufacturing #Conference